Concurrent radiochemotherapy in the treatment of locally advanced non–small cell lung cancer

This publication has 44 references indexed in Scilit:

• Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504
  Journal of Clinical Oncology, 2003
• Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2003
• Prospective randomized study of four novel chemotherapy regimens in patients with advanced nonsmall cell lung carcinoma
  Cancer, 2002
• Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non–Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019
  Journal of Clinical Oncology, 2002
• Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
  New England Journal of Medicine, 2002
• Continuous, hyperfractionated, accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small cell lung cancer: mature data from the randomised multicentre trial
  Radiotherapy and Oncology, 1999
• Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of radiation therapy oncology group 90-15
  Cancer, 1995
• Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary Results of a Phase III Trial in Regionally Advanced, Unresectable Non-Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 1995
• Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
  New England Journal of Medicine, 1992
• Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung Carcinoma
  JNCI Journal of the National Cancer Institute, 1992